van der Noort Vincent - Dept Biometr, Netherlands Canc Inst

基本信息

浏览量：46

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 162 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Blood platelet RNA profiles do not enable for nivolumab response prediction at baseline in patients with non-small cell lung cancer

Mirte Muller,Myron G Best,Vincent van der Noort,T Jeroen N Hiltermann,Anna-Larissa N Niemeijer,Edward Post,Nik Sol,Sjors G J G In 't Veld,Tineke Nogarede,Lisanne Visser,Robert D Schouten,Daan van den Broek,

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicineno. s1 (2024): S327-S340

引用0浏览0WOS引用

Penile cancer care in the Netherlands: increased incidence, centralisation, and improved survival

Manon T. A. Vreeburg, Hielke-Martijn de Vries,Vincent van Der Noort, Simon Horenblas,Bas W. G. van Rhijn, Kees Hendricksen,Niels Graafland, Henk G. van Der Poel,Oscar R. Brouwer

BJU INTERNATIONALno. 5 (2024): 596-603

引用0浏览0WOS引用

1392P Safety and efficacy of crizotinib in MET mutated (METmut) advanced non-small cell lung Cancer (aNSCLC): Results from the Drug Rediscovery Protocol (DRUP)

K. Verkerk, T. van der Wel, L.J. Zeverijn, B.S. Geurts, I.A.C. Spiekman,G.F. de Wit, P. Roepman, A. Jansen,V. van der Noort,E.F. Smit, A. Hoeben, L. Hendriks,

Annals of Oncology（2023）

引用0浏览0引用

Pembrolizumab plus lenvatinib in second-line and third-line patients with pleural mesothelioma (PEMMELA): a single- arm phase 2 study

Li -Anne H. Douma,Ferry Lalezari,Vincent van der Noort, Jeltje F. de Vries,Kim Monkhorst,Illaa Smesseim,Paul Baas, Bodien Schilder, Marrit Vermeulen,Jacobus A. Burgers,Cornedine J. de Gooijer

The Lancet. Oncologyno. 11 (2023): 1219-1228

引用1浏览0WOS引用

1818P Final results from a randomized phase II study of cabazitaxel (CBZ) versus an androgen receptor targeted agent (ARTA) in patients with poor-prognosis castration-resistant prostate cancer (mCRPC)

K. van der Zande,V. van der Noort,M. Busard,P. Hamberg, S. Ras - van Spijk,J. de Feijter, V. Dezentje, M. Tascilar, D. Houtsma,A. Beeker, P. van den Berg, D. ten Oever,

JOURNAL OF CLINICAL ONCOLOGY（2023）

引用3浏览0引用

Clinical activity of palbociclib and ribociclib monotherapy in advanced cancers with cyclin D-CDK4/6 pathway alterations in the Dutch DRUP and Australian MoST trials

Laurien Joanna Zeverijn,Eleonora Looze,Subotheni Thavaneswaran,Jade M. van Berge Henegouwen,John Simes,Louisa Rose Hoes,Birgit Geurts,Lucille Sebastian,Paul Roepman,Frank Po-Yen Lin,Anne M. L. Jansen,Wendy W. J. de Leng,

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2023): 3101-3101

引用0浏览0引用

Does Prophylactic Replacement of Voice Prosthesis Make Sense? A Study to Predict Prosthesis Lifetime

Anne N Heirman,Vincent van der Noort,Rob van Son,Japke F Petersen,Lisette van der Molen,Gyorgy B Halmos,Richard Dirven,Michiel W M van den Brekel

Otolaryngol Head Neck Surg（2023）

引用0浏览0WOS引用

Histopathological concordance between prostate biopsies and radical prostatectomy specimens—implications of transrectal and transperineal biopsy approaches

M. J. Hagens, L. L. A. Ribbert, A. Jager, H. Veerman, K. Barwari, B. Boodt, R. E. de Bruijn, A. Claessen, M. R. Leter,V. van der Noort, M. Smeenge, T. A. Roeleveld,

Prostate Cancer and Prostatic Diseases（2023）

引用0浏览0WOSNATURE引用

1710P Protocol waivers and consequences on treatment safety and efficacy in the Drug Rediscovery Protocol (DRUP)

L.J. Zeverijn,J.M. van Berge Henegouwen, B.S. Geurts,G.F. de Wit, L. Hoes,H. van der Wijngaart,V. van der Noort, A.D.R. Huitema, F.Y.F.L. De Vos, K. Grunberg, H. Bloemendal, H.M.W. Verheul,

Annals of Oncology (2023): S933-S933

引用0浏览0引用

Efficacy, safety and biomarker analysis of durvalumab in patients with mismatch-repair deficient or microsatellite instability-high solid tumours

Birgit S. Geurts,Thomas W. Battaglia,J. Maxime van Berge Henegouwen,Laurien J. Zeverijn,Gijs F. de Wit,Louisa R. Hoes,Hanneke van der Wijngaart,Vincent van der Noort,Paul Roepman,Wendy W. J. de Leng,Anne M. L. Jansen,Frans L. Opdam,

BMC Cancer（2023）

引用3浏览0WOS引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn